You have 9 free searches left this month | for more free features.

radioligand therapy

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Microglia in the Pathogenesis of Progressive Multiple Sclerosis

Active, not recruiting
  • Multiple Sclerosis
    • Turku, Finland Proper, Finland
      Turku PET Centre
    Oct 12, 2022

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • Toronto, Ontario, Canada
      University Health Network - Princess Margaret Cancer Centre
    Aug 16, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • 1.11GBq of 177Lu-EB-PSMA-617
    • +2 more
    • Beijing, China
      Peking Union Medical College Hospital
    May 6, 2022

    Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)

    Recruiting
    • Metastatic Prostate Cancer
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    Sep 17, 2023

    Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

    Recruiting
    • Salivary Gland Cancer
    • Salivary Duct Carcinoma
    • 68Ga-PSMA-PET/CT
    • 18FDG-PET/CT
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Aug 15, 2022

    Prostate Cancer Metastatic, Castration Resistant Prostatic Cancer, Advanced Prostate Carcinoma Trial in Homburg

    Recruiting
    • Prostate Cancer Metastatic
    • +2 more
      • Homburg, Saarland, Germany
        Dept. of Nuclear Medicine, Saarland University
      Apr 4, 2021

      Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

      Not yet recruiting
      • Newly Diagnosed Glioblastoma
      • (no location specified)
      Feb 13, 2023

      Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

      Not yet recruiting
      • Cancer
      • [177Lu]Lu-PSMA I&T
      • Meldola, Forlì, Italy
      • +1 more
      May 10, 2023

      Prostatic Tumor Trial in Amsterdam, Utrecht (177Lu-PSMA-617, EBRT)

      Recruiting
      • Prostatic Neoplasm
      • Amsterdam, Netherlands
      • +1 more
      Dec 21, 2021

      Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)

      Suspended
      • Prostate Cancer
      • Vancouver, British Columbia, Canada
      • +3 more
      Jun 13, 2022

      Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide ([Lu-177]-PNT2002, Abiraterone, Enzalutamide)

      Recruiting
      • Metastatic Castration-Resistant Prostate Cancer
      • Tucson, Arizona
      • +47 more
      Jun 1, 2022

      Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)

      Not yet recruiting
      • Prostate Cancer
      • Localized Prostate Carcinoma
      • PSMA-1007 Positron Emission Tomography (PET) scan
      • (no location specified)
      Aug 14, 2023

      Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

      Not yet recruiting
      • Castration-Resistant Prostate Carcinoma
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Jun 20, 2023

      Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,

      Active, not recruiting
      • Metastatic Prostate Cancer
      • +4 more
      • Duarte, California
      • +26 more
      Aug 3, 2022

      Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Irvine, Chicago, Boston

      Not yet recruiting
      • Advanced Solid Tumor
      • +4 more
      • Irvine, California
      • +2 more
      Nov 27, 2023

      Solid Tumor Trial in United States (68Ga-FAP-2286, 177Lu-FAP-2286)

      Recruiting
      • Solid Tumor
      • Birmingham, Alabama
      • +5 more
      Aug 26, 2022

      Breast Cancer Trial in Madison (drug, device, other)

      Not yet recruiting
      • Breast Cancer
      • Madison, Wisconsin
        UW Carbone Cancer Center
      Oct 11, 2023

      HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)

      Not yet recruiting
      • HIV Associated Neurocognitive Disorder
      • +3 more
      • SV2A PET
      • TSPO PET
      • (no location specified)
      Oct 16, 2022

      Measuring Active Microglia in Progressive Multiple Sclerosis

      Completed
      • Secondary Progressive Multiple Sclerosis
      • [C11]PK-1195 PET scan
      • New York, New York
        Weill Cornell Medical College
      Jan 14, 2022

      Prostate Cancer Trial in Bern (18F-PSMA-1007, 68Ga-PSMA-11)

      Recruiting
      • Prostate Cancer
      • 18F-PSMA-1007
      • 68Ga-PSMA-11
      • Bern, Switzerland
        Inselspital, Universitätsspital Bern
      Jul 4, 2022

      Prostate Cancer Trial in Québec (Enzalutamide capsule)

      Recruiting
      • Prostate Cancer
      • Enzalutamide capsule
      • Québec, Canada
        CHU de Québec-Université Laval
      Mar 29, 2022

      Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

      Recruiting
      • Castration-Resistant Prostate Carcinoma
      • +4 more
      • San Francisco, California
        University of California San Francisco
      Feb 27, 2022

      Germ Cell Tumor, Seminoma, Nonseminomatous Germ Cell Tumor Trial in Duesseldorf (Robot-assisted ICG-guided sentinel lymph node

      Recruiting
      • Germ Cell Tumor
      • +2 more
      • Robot-assisted ICG-guided sentinel lymph node biopsy
      • Duesseldorf, Germany
        University Hospital of Duesseldorf
      Nov 10, 2023

      Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

      Not yet recruiting
      • Prostate Cancer
      • [177Lu]Lu-PSMA I&T
      • Stereotactic Radiotherapy
      • (no location specified)
      May 30, 2023

      Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)

      Recruiting
      • Neurodegenerative Diseases
      • +2 more
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jan 24, 2023